This paper examines the diversity of linkages of firms to science and their effect on innovation performance for a sample of Belgian firms (CIS-3). While at the sectoral level links to science are highly related to the R&D intensity of the sector, we show that there exists considerable heterogeneity in the type of links to science at the firm level. Overall, firms with a science linkage -which can be of various sorts -enjoy a superior innovation performance, in particular with respect to innovations new to the market. At the invention level, our findings confirm that patents from firms engaged in science are more frequently cited and have a broader technological and geographical impact, but we show that it is crucial to distinguish between direct science links at the invention level and indirect science links at the firm level to encounter these distinct positive effects of science links. Therefore, Science & Technology indicators should control for both invention level and firm level science links to really account for the effect of these industry-science links.
Introduction
An important and recurrent concern in economics has been to understand to what extent science influences technological progress. The answer to this question has profound implications for public policy, notably on the decision whether and how to fund public research and investment in basic research by industry. The works by Jaffe (1989) and Adams (1990) have shown the importance of basic research for economic growth while research by Acs, Audretsch and Feldman (1992) and others, have revealed the significant externalities stemming from local academic research. Numerous studies have thus attempted to quantify these effects. The rates of return to publicly funded research, for example, have been estimated between 20% and 60% (Salter and Martin, 2001) . This literature has shown that knowledge flows from universities and public research centres make a substantial contribution to industrial innovation and, consequently, to public welfare. 1 More recent research suggests that the links to basic research by industrial firms have dramatically increased in the last decade and that firms today manifest a diversity of links.
There is evidence of rising university spin-offs (Jansen and Thursby, 2001; Thursby and Thursby, 2002) , university-industry collaboration (Liebeskind et al, 1996; Darby and Zucker; Zucker et al, 2001; , mobility of university researchers (Kim et al, 2005) , sciencelinkage in private patents (Narin et al, 1997; Hicks et al, 2001) , and so forth. Narin et al (1997) , for instance, report a threefold increase in the number of academic citations in industrial patents in the United States through the mid 1990s.
2 These patterns suggest an increased opportunity for innovation offered by scientific institutions. 1 The importance of academic research for industrial innovation has also been corroborated in studies based on industrial survey and patent statistics (Mansfield, 1991 (Mansfield, , 1995 Cohen, Nelson and Walsh, 2002) . 2 Narin, Hamilton, Olivastro (1997) , Branstetter (2004) , and Van Looy et al (2004) , have all confirmed an increasing citation to academic publications in patents
In spite of these growing connections to science our understanding of the variety and distribution of these links, of how these knowledge transfers take place through these links and how they affect industrial innovation remains unclear. The main incentive for enterprises to engage in industry science links is to access scientific know how and knowledge. By providing a map of the research environment and current understanding of science, science helps firms to avoid wasteful experimentation by focusing on the most promising research paths, thereby increasing the productivity of own internal research (Evenson and Kislev, 1976; Gambardella, 1992) . Past work has focused on research partnerships as mechanism for firms to engage in industry-science relations (Cockburn and Henderson, 1998; Zucker et al, 2001; Belderbos et al, 2005) and has shown that university-industry connections contribute to increased firm research productivity; but that their contribution depends upon the firms' research capabilities and abilities to absorb scientific knowledge. However, due to the highly specific nature of the know-how involved, only a select set of firms within specific industries tend to show strong interest in the scientific know-how offered by universities or other science institutes. Evidence from the European community innovation surveys (CIS) indicate that 31% of firms characterized as "novel innovators" indicate science to be an important source of information, compared to a mere 4% of all firms who find these information sources important (EC-DGECFIN, 2000) . Therefore, it seems that science is more important as source of information for innovation in those science-based technology fields where new breakthrough innovations (i.e. radical innovations) can be achieved and transferred to new products and processes.
In this article, we shed some light on the debate of industry-science linkages by looking at the "diversity" of linkages to science employed by Belgian firms and their relationship to innovative performance. For this purpose, we use the data available from the CIS-3 (Community Innovation Survey) conducted in 1998-2000, and combine it with information on the use of science by firms through patent and publication information. The science linkages considered in this analysis are: i) cooperation with public research centers and universities, ii) use of public information sources to innovate, iii) citation to scientific literature in patents and, iv) involvement in scientific publication. Hence, as a first contribution of the paper, we provide a broader picture of the distribution of different links to science employed by manufacturing firms.
In order to better understand the reliance on science by industrial firms, a second contribution of this paper consists in evaluating whether science linkages enhance industrial innovation and economic performance. Two levels of analysis are presented. First, we relate linkages to science to the different indicators of innovation at the firm level (turnover due to innovation and turnover due to market introduction as reported in the CIS 1998-2000 data). Second, we delve into the micro-level connections between science and innovation performance, focusing on the invention (i.c. patent) level. For this we restrict the sample to patenting firms and compare the differences in patent quality (forward citation) between patents by firms with science linkages vis-à-vis patents of other firms. In this way, this work provides an evaluation of the effectiveness of the science-linkages to enhance technological performance by looking at the quality of private inventions.
This paper consists of five sections. Section I presents a summary of the literature and reviews previous empirical work on the value of science for industrial innovation. Section II describes our data, the frequency of science link strategies, and the adoption of science linkages across industries. Section III presents an evaluation of the relationship between science linkages and firms' innovation performance. The final section concludes and identifies some policy implications.
I.

The value of Science
Using a diversity of methodologies, economists have since long time attempted to asses the economic payoffs of basic research. Relying on the assumption of informational properties of basic research (non-rival and non-excludable; Arrow, 1962; Dasgupta and David, 1994) , economists such as Griliches (1979) and Adams (1988; have shown the important contribution of basic research (e.g. public research expenditures and scientific publications) to economic growth. Complementary research based on survey studies, has provided an alternative estimation of the contribution of basic research for industrial innovation and economic performance. In a survey of 76 U.S. firms in seven industries, Mansfield (1991) obtained estimates from company R&D managers about what proportion of the firms' products and processes over a 10-year period could not have been developed without academic research.
He found that 11% of new product innovations and 9% of process innovations would not have been developed (without substantial delay) in the absence of recent academic research; these innovations represented respectively 3% and 1% of sales.
Both the 1983 Yale Survey and the 1994 Carnegie Mellon Survey of R&D have also shown the relevance of university research for industrial innovation (Cohen et al, 2002 3 The results indicate that the key channels through which university research impacts industrial R&D include published papers and reports, public conferences and meetings, informal information exchange, and consulting.
Several advantages have been associated with the use of science to explain the innovation performance of firms. These include an increase in productivity and level of applied research effort (Evenson and Kislev, 1976) , substantial gains in overall R&D productivity (Henderson and Cockburn, 1996; Gambardella, 1992) , the development of absorptive capacity (Arora and Gambardella, 1990; , and, labor cost reductions (Stern; 1999) , among others. Science reduces the amount of duplication of effort (Arrow, 1962; Nelson, 1982; Dasgupta and David, 1994) . As science serves as a map of the technological landscape it allows private research to focus on the most promising technological venues avoiding thereby wasteful experimentation (Fleming and Sorenson, 2004) . 4 Furthermore, the development of a higher absorption capacity related to the generality of basic research; has frequently been argued to be one of the main advantages of conducting science. It permits the firm to more easily identify and integrate external information, enhancing the productivity of internal research 1989; .
Other benefits are associated to the recruitment of scientists where the adoption of propublication incentives for employees helps firms attract high quality academic researchers whose economic value might frequently be higher than their actual remuneration. Stern (1999) has shown that researchers looking for academic reputation, may want to pursue research projects leading to publications and are, therefore, prompt to accept lower salaries in exchange of permission to keep up with scientific research. These researchers provide value along two dimensions; they not only generate important labor costs reductions but also constitute a "bridge" ('gatekeepers' and "boundary spanners") with the scientific or academic world.
In spite of such apparent benefits, the adoption of science by private firms remains limited to a very specific kind of organization. Due to the highly specific nature of the know-how involved, only a select set of firms within specific industries tend to show strong interest in the scientific know-how offered by universities or other science institutes. A number of conditions to successfully embrace science have been put forward. Engagement into science is not costless; it is highly conditional on human capital and adoption of new organizational practices (Gambardella, 1995; Cockburn et al, 1999) . The need for new information for innovation differs across industries and is highly dependent of the degree of maturity and the emergence of new technologies (Nelson and Winter, 1982) . When industries are shaken up by technological change for which their competences have become obsolete, they are required to cross organizational and industry boundaries and engage in networking with the new actors.
Nevertheless, for firms seeking to overcome their lack of upfront knowledge through cooperation with universities and public research centers; the interaction is not an easy task.
The literature has shown that industry-university links are subject to important tensions regarding intellectual property, access and dissemination policies (open science is by definition based on early and large diffusion through publication), and others, inhibiting the chances of successfully translating scientific information into new products (Jansen and Thursby, 2001; Thursby and Thursby, 2002; Hall et al, 2001; Poyago-Theotoky et al, 2002) . For instance, in a survey based study on 38 Advanced Technology Projects (ATP), Hall et al (2001) found that projects with university involvement tend to be in areas involving "new" science and therefore experience more difficulty and delay but also are more likely not to be aborted prematurely. 5 In a sample of 62 U.S. university licensing officers, Jensen and Thursby (2001) find that over 75% of the inventions licensed by these universities were in a very early, or embryonic stage. Further, 71% of the inventions licensed required cooperation between the professor and the licensing firm in order to commercialize a product successfully. Relying on the CIS for Belgium, Veugelers and Cassiman (2005) , find that cooperation with universities is formed whenever risk is not an important obstacle to innovation.
Mostly focused at the firm-level of analysis, the empirical literature has previously assessed the role of scientific-connections, notably partnerships with university researchers, on firm performance (e.g. Audretsch and Stephan, 1996; Zucker et al 1998; Cockburn and Henderson, 1998) . Using university collaboration as a scientific-link, these papers seem to support the hypothesis that these links boast internal R&D investment (Adams et al, 2000) , innovation productivity and sales (Belderbos et al, 2005) . 6 While they provide little explanation about the process through which science affects private innovation, the studies relying on the "production function" have found that science involvement and ties with academic star scientists-, lead to more technology (Henderson and Cockburn, 1996; Zucker et al, 2002; Cockburn and Henderson, 1998) ; more "important" patents: i.e. international patents (Henderson and Cockburn, 1994) ; and higher average of quality adjusted patenting Zucker et al, 2002) .
The work of Cockburn and Henderson (1998) has shown that not only absorption capacity (Cohen and Levinthal, 1989; Kamien and Zang, 2000) in basic research matters but also closeness to scientific communities. Using data on co-authorship of scientific papers for a sample of pharmaceutical firms, they show that firms connected to science show a higher performance in drug discovery and that this connectedness is closely related to the number of star scientists employed by the firm. 7 Zucker et al (1998) and Darby and Zucker (2001; found that location of top star scientists predicts firm entry into biotechnology (by new and existing firms) both in the United States and Japan, while Darby and Zucker (2005) recently provided evidence that firms enter nanotechnology where and when scientists are publishing 6 For instance, Lööf and Broström, (2004) have found complementarities between internal R&D and collaboration with universities: the average R&D firm that cooperate on innovation with universities spend more money on R&D and has a larger propensity to apply for patents compared to an almost identical R&D firm which has no such collaboration. 7 Differences in the effectiveness with which a firm is accessing the upstream pool of knowledge correspond to differences in the research productivity of firms of as much as 30%.
breakthrough academic articles. 8 For biotechnology in Japan, Darby and Zucker (2001) show that collaborations between particular university star scientists and firms had a large positive impact on firm research productivity, increasing the average firm's biotech patents by 34 percent, products in development by 27 percent, and products on the market by 8 percent as of 1989 . Zucker et al (2002 found that the impact of 'tied' star scientists (those that collaborate with firms) on patents and the number of products on development was significantly larger and beyond the effects of all other scientists from top research universities working with the firm; no effect was reported for untied science.
II. The diversity of Linkages to Science
Data on firms' research strategies comes from the Third Community Innovation Survey (1998) (1999) (2000) conducted by Eurostat in Belgium in 2000. Two methods were employed in the CIS-3 for Flemish firms. First, from a population of 9292 firms (those having more than 250 employees), 2726 firms were contacted by traditional mail. From this sample, 684 firms replied and answered correctly the survey, giving a response rate of 25.1%. Giving such a low score, a second round of questionnaires was made electronically using the CAPI (Computer Aided Personal Interview). A total of 1471 responses were obtained using the two methods. In this paper, we limit our sample to the 842 manufacturing firms that are engaged in innovation activities and define the following linkages to science:
i)
A dummy indicating whether the firm has been engaged in formal cooperation in R&D (status) with universities or governmental research centers (both national and international).
ii)
A dummy indicating whether the firm considers public information a very important source for innovation (firms scoring "3" of a scale of three for "using" scientific information being very important).
iii)
A dummy indicating whether the firm is engaged into collaboration with universities or public research centers and at the same time, considers public information as a very important source for innovation.
iv)
A dummy indicating whether the firm has been engaged into publication activity: takes Table 1 and 2 show the distribution of firms across the different science linkages and across sectors. Corroborating previous research; the use of science and cooperation with universities and public research centers by Belgian firms is limited to some firms but there is some diversity in the ways to access scientific knowledge. The first finding that emerges from these tables is the few occurrences of connections to science relative to the population (manufacturing firms).
74,82% of these firms do not have any linkage to scientific communities. The Table 2 , not surprisingly, shows that the low R&D intensive industries have the highest percentage of firms not having any connection to science (82%) while the opposite is found in the high R&D intensive industries. Confirming previous studies, this latter group of industries report the highest percentage of firms engaged into scientific linkages (relative to the total number of firms): 25% of firms are engaged into cooperation with public institutions, 33% consider the use of public information as very important for innovation; while 16% declare to be engaged in both strategies. This is related to the sectoral correlation seen in Table 1 where Electronics; and Medical and precision instruments followed by chemicals (within pharmaceuticals), coke petroleum score high on all types of science links. Some interesting industry variation in the relative use of science links emerges across sectors from Table 1 publication, and more surprising; 5 of these 9 firms are found in the medium low R&D intensive industries. 9 These simple descriptive statistics corroborate the heterogeneity that exists in the ways to access scientific knowledge but also reveals that some additional information is found in the science-linkage reported in publications and patents.
III. Performance of Linkages to Science
In this section we evaluate whether science linkages enable firms to achieve higher innovation and economic performance. Following the literature previously exposed, it is expected that firms connected to science develop comparative advantages in the production of innovation and notably, in the production of breakthrough innovation. The linkages to science by facilitating absorption and understanding of fundamental knowledge, allow firms to follow new discoveries, upgrade internal technological competences, and detect new opportunities for industrial innovation. We present two levels of analysis. First, we relate linkages to science to the indicators of innovation and economic performance at the firm level reported in the CIS 1998-2000 data. The key measure of innovation is innovation new to the market, and the indicators of economic performance are turnover due to innovation and turnover due to market introduction. 9 We follow the criteria hold by the OECD (OECD Science and Technology, 2001 Second, we provide an additional measure of innovation performance within the firm at the invention level, but controlling for firm level science links. We compare the differences in patent quality (forward citation) 10 of patents of firms with science linkages vis-à-vis patents of other firms, for the sub-sample of patenting firms. Previous empirical research has shown that academic patents, because they rely on more fundamental knowledge, are broader in scope and cited more frequently than private patents (e.g. Jaffe et al, 1993; Henderson et al, 1998) .
Analyses of patent citations find that academic papers and university patents are more frequently cited than their equivalents from private firms, suggesting that public science is an important input for the innovative activities of firms (Jaffe et al., 1993; Narin et al., 1997) . Yet, there is no evidence about the effectiveness of science to explain the technological impact of private patents. 11 In this way, by looking at the invention level we want to validate the meaning of citation to scientific literature in patents and assessing whether these (few) firms are indeed capable of a higher technological performance either through a direct reference to science or and indirect link at the firm level. firms having introduced radical innovations (63%). Firms with this science link also display the highest innovation turnover ratio and turnover due to market introductions, but these firms are also larger and have a significantly higher R&D intensity. While firms with different links do display significant differences in size and R&D intensity, the differences in innovation output is not significant.
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III.A. Science linkages and Economic Performance
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The correlation matrix in Table 4 offers additional insights on the correlation of science linkages respect to performance. Consistent with our finding about the diversity in science links of firms, we find that having a link (column 1) has the highest correlation with the innovation turnover ratio, the new market innovations turnover ratio and the new market introduction indicator, while no one specific link seems to account for this positive effort. In addition, except for the importance of public information, all correlations are stronger for new market introductions relative to overall innovation.
13 Small sample size is clearly an issue here.
III.B. Science linkages and quality of patents
We now look at the differences in the quality of inventions (patents) respect to the linkages to science. The sample consists of 1161 patents from 79 firms for which patents from the European Patent Office have been found. These patents are granted patents with grant date 1995-2001. Their forward citation rate is computed up to the most recent year available in our EPO-ESPACE B database, which is 2003. Past research has shown that the number of citations a patent receives is highly associated with its technological importance) and social value (Trajtenberg, 1990 ) and correlated to the renewal of patents, the estimated economic value of inventions and patent opposition (Lanjouw and Schankerman, 1999; Harhoff et al, 1999; Hall et al, 2000; Harhorff et al; 1999) .
We have also computed two indicators of technological impact based on forward citations: generality and geographical dispersion. The generality measure has been used as an indication of the impact of a patent, a high generality score suggests that the patent presumably had a widespread impact, in that it influenced subsequent innovations in a variety of fields (Hall et al, 2001 ). This indicator is build as a Herfhindal index (Jaffe et al, 1997; Hall et al, 2001 ):
, where s The breakdown of patent quality measures across the science linkages of firms is reported in Table 5 including some t-tests (one tailed) on the comparison of means. As expected, firms having at least one link (any) to scientific communities report a higher frequency of being cited, they appear more general in scope (are more cited across different technology classes, IPC) and have a higher geographical dispersion. However, the difference in means is significant (at 10%) only for geographical dispersion and the frequency of being cited at least once (dummy for forward citation). Firms that cooperate or use public sources of information report 0,70 citations on average and firms involved directly in science through publication report an average of 0,72 forward citations. These effects are however marginally significant. We confirm the superior performance in terms of patent quality from firms engaged into science linkages: firms engaged into cooperation or considering public information as very important;
and notably, firms engaged into publication have all a higher citation likelihood and higher mean of forward citation respect to patents from firms lacking such linkage (the t-tests are however weakly significant).
Comparing patents with scientific references (NPRs) to patents without scientific references we find that patents without NPRs are more likely to be cited (33% versus 24%) and have a higher mean of forward citations, but patents with NPRs are more general and more geographically dispersedly cited. The difference in means between patents having a scientific NPR and those lacking such references are significant only for generality and forward citation probability. This suggests that while patents with scientific references protect broad technologies, more applied patents -patents without scientific references -actually capture the value for the firm. Thus patents citing a scientific publication appear to cover more fundamental knowledge and they are therefore more likely to be cited across a broad rang of technology classes and across countries. This kind of patents however is less likely to be cited and not different from the rest of patents in the average count of citation received. This finding may suggest that is not easy to everyone to invent around basic patents and that those that cite that patents, may be a very specific kind of inventor being able to follow on technology based on very upfront knowledge.
Finally, in Table 6 we control for firm level science links and compare patent quality between firms with and without science links. In the first panel we consider only firms with scientific publications and look at the quality of patents with and without scientific references. We confirm that patents with scientific references are more general and citations are more geographically dispersed, but they are less likely to be cited. However, and more interestingly, comparing the forward citations of patents without scientific references of these firms with patents without scientific references of other firms (that have no publications), we find that these patents are more likely to be cited and receive more citations. Our interpretation is that firms with scientific publications not only have patents with scientific references, but also have higher quality applied patents thanks to their more basic knowledge of the technology. This result is confirmed for firms that consider public sources of information very important. Patents from firms that engage into cooperation -with NPR and without NPR-appear both superior to the their counterpart -from firms not engaged into cooperation-; in terms of citation likelihood.
We, therefore, conclude that controlling for the firm level science links when evaluating patent quality is crucial to pick up the innovation performance effect of these science links -the higher new to market innovation content of these innovations.
IV. Conclusions
This paper examines the diversity of science linkages to science and their association to innovation performance for a sample of Belgian firms (CIS-3). We identify different ways to access scientific knowledge through CIS indicators and add additional measures on the use of science by firms by analyzing publication data and citations to science in these firms' patents.
We confirm findings in the literature that firms with science linkages seem to enjoy a superior innovation performance. Furthermore, we show that at the invention level patents from firms with links to science are more frequently cited and have a broader technological impact.
While our sample of firms is limited, we nevertheless provide some clear direction for the development of indicators for these Industry -Science Links (ISL):
There are a diverse set of possible indicators of ISL such as cooperation with public research institutes and universities; the importance of public information; publications by the firms; references to scientific literature in the firms' patents; etc… While at the industry level ISL is correlated with R&D intensity of the industry, a lot of variation at the firm level exists, i.e. there is not that much overlap between different types of ISL at the firm level.
No one indicator is a sufficient statistic for the effect of ISL on innovation performance.
Having a link to science is highly correlated with the innovation performance of firms, in particular products new to market, but no one indicator seems to dominate this effect.
At the invention level we distinguish between the effect of direct science links and indirect -firm level science links on patent quality. Direct science links, the references to science in the patents, are related to more general and more widely cited patents. This link, therefore, captures the depth of the technological knowledge base of the firm. The indirect science link at the firm level (publications, cooperation, public information)
demonstrates that patents without any direct science link are more widely cited than comparable patents of firms without such an indirect link to science.
In conclusion, our results indicate that several indicators need to be tracked to obtain a representative picture of the ISL activity of a country. In addition, to bring out the true effect of these links, firm and invention level indicators need to be interacted. Note: Only Cooperation with Public Institutes: firms that declare cooperating with universities and/or public research institutes (either national and international) as the only mean of accessing scientific knowledge. Only Use of Public sources: firms that consider public information sources as very importante for innovation (score=3). The sources of information are: from universities or other higher education institutes, government or private non profit research institutes and from professional conferences, meeting and journals. Note: * signicant correlation at 5% and better. 
